We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Predictive Oncology Inc (POAI) USD0.01

Sell:$0.85 Buy:$0.86 Change: $0.0409 (4.59%)
Market closed |  Prices as at close on 18 January 2022 | Switch to live prices |
Change: $0.0409 (4.59%)
Market closed |  Prices as at close on 18 January 2022 | Switch to live prices |
Change: $0.0409 (4.59%)
Market closed |  Prices as at close on 18 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Predictive Oncology Inc. is a data and artificial intelligence (AI)-driven discovery services company. The Company provides predictive models of tumor drug response that are used to improve clinical outcomes for patients. It operates through three segments: Helomics, Skyline and Soluble. Helomics segment includes clinical testing and contract research services that include the application of AI. Soluble segment provides services using a self-contained, automated system that conducts throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. Skyline segment consists of the STREAMWAY System product sales. Its three primary business areas includes application of AI, production of system for automated, direct-to-drain medical fluid disposal and associated products, and contract services and research.

Contact details

2915 Commers Dr Ste 900
United States
+1 (651) 3894800

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$58.42 million
Shares in issue:
65.58 million
Health Care Supplies
United States
US dollar

Key personnel

  • J. Melville Engle
    Chairman of the Board, Chief Executive Officer
  • Carl Schwartz
  • Robert Myers
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.